Form 10-Q HORIZON PHARMA, INC. For: Jun 30

Go back to Form 10-Q HORIZON PHARMA, INC. For: Jun 30

Horizon Pharma (HZNP) Tops Q2 EPS by 11c

August 7, 2014 6:57 AM EDT

Horizon Pharma (NASDAQ: HZNP) reported Q2 EPS of $0.21, $0.11 better than the analyst estimate of $0.10. Revenue for the quarter came in at $66.1 million versus the consensus estimate of $58.35 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

... More